Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | Chief Legal Officer | February 08, 2026 | February 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date February 08, 2026 · Filed February 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,605 |
Ending reported balance
After 2026-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-08 · Grant · Acquired 3,198 · Balance 42,753 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2026-02-08 · Tax withholding · Disposed 1,148 · Balance 41,605 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,198 |
Reported balance
After 2026-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-08 · Exercise / conversion · Disposed 3,198 · Balance 3,198 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 1
1 source rowRow 1 · 2022-05-27 · Disposition to issuer · Disposed 708 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $188.95 · Expires 2030-12-01 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-27 · Disposition to issuer · Disposed 2,105 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-27 · Disposition to issuer · Disposed 1,892 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Disposition to issuer · Disposed 6,438 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 714 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 1,420 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 1,260 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 1,559 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 11,910 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 6,439 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 7,256 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 1,020 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 204 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F16: 204 shares will vest on January 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024.
F4: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F5: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026.
F6: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F8: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024.
F9: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
F10: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025.
F11: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
F12: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024.
F13: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
F14: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F16: 204 shares will vest on January 31, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2024 Filed Nov 12, 2024 20:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,417 | $43.75 | $61,993.75 |
DisclosureSEC source: 0001906324-24-000055 · wk-form4_1731460681.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,514 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 20:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-24-000055 · wk-form4_1731460681.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,931 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-115349 · ownership.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390 Underlying: Common Stock · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025. F4 · derivative.expiration_date: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommom Stock | 140 | $40.20 | $5,628.00 |
DisclosureSEC source: 0000950170-24-115349 · ownership.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,961 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-115349 · ownership.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,101 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 25, 2024 Filed May 29, 2024 16:44 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066018 · ownership.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 420 shares vested on May 25, 2024; the remaining 420 shares will vest on May 25, 2025. F4 · derivative.expiration_date: 420 shares vested on May 25, 2024; the remaining 420 shares will vest on May 25, 2025. Read SEC document |
| May 25, 2024 Filed May 29, 2024 16:44 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 150 | $42.40 | $6,360.00 |
DisclosureSEC source: 0000950170-24-066018 · ownership.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,711 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 25, 2024 Filed May 29, 2024 16:44 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066018 · ownership.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,861 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 13, 2024 Filed May 15, 2024 16:51 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 11,873 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-060560 · ownership.xml · derivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,873 Underlying: Common Stock · 11,873 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 11,873 shares will fully vest on June 30, 2025. F2 · derivative.expiration_date: 11,873 shares will fully vest on June 30, 2025. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 2,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039663 · ownership.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,926 Underlying: Common Stock · 2,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 2,462 shares vested on March 28, 2024; the remaining 4,926 shares will vest in equal installments on March 28, 2025 and March 28, 2026. F4 · derivative.expiration_date: 2,462 shares vested on March 28, 2024; the remaining 4,926 shares will vest in equal installments on March 28, 2025 and March 28, 2026. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 879 | $47.94 | $42,139.26 |
DisclosureSEC source: 0000950170-24-039663 · ownership.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,441 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 2,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039663 · ownership.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,320 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:42 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 9,593 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014146 · ownership.xml · derivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,593 Underlying: Common Stock · 9,593 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F1 · derivative.exercise_date: 3,197 shares will vest on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. F1 · derivative.expiration_date: 3,197 shares will vest on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:42 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Option · Derivative | 9,593 | $0.00 Strike: $67.02 | $0.00 |
DisclosureSEC source: 0000950170-24-014146 · ownership.xml · derivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,593 Underlying: Common Stock · 9,593 shares Expires 2034-02-08 F1 · derivative.exercise_date: 3,197 shares will vest on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. Read SEC document |
| February 08, 2024 Filed Feb 16, 2024 16:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Premium) · Derivative | 260 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016353 · ownership.xml · derivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260 Underlying: Common Stock · 260 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F4 · derivative.exercise_date: The restricted stock units vest on February 8, 2025. F2 · derivative.expiration_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F4 · derivative.expiration_date: The restricted stock units vest on February 8, 2025. Read SEC document |
| February 08, 2024 Filed Feb 16, 2024 16:07 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Converted) · Derivative | 868 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016353 · ownership.xml · derivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 868 Underlying: Common Stock · 868 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F3 · derivative.exercise_date: The restricted stock units vested on February 8, 2024. F2 · derivative.expiration_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F3 · derivative.expiration_date: The restricted stock units vested on February 8, 2024. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011466 · ownership.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473 Underlying: Common Stock · 473 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 473 shares vested on February 1, 2024; the remaining 474 shares will vest on February 1, 2025. F4 · derivative.expiration_date: 473 shares vested on February 1, 2024; the remaining 474 shares will vest on February 1, 2025. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 169 | $69.45 | $11,737.05 |
DisclosureSEC source: 0000950170-24-011466 · ownership.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,858 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011466 · ownership.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,027 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 12 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 11 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,020 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 10 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,628 Underlying: Common Stock · 3,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,628 shares vested on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: 3,628 shares vested on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 9 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,220 Underlying: Common Stock · 1,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,610 shares vested on January 31, 2024; the remaining 3,220 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 1,610 shares vested on January 31, 2024; the remaining 3,220 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 73 | $68.51 | $5,001.23 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 8 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,554 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 7 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,627 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 340 | $68.51 | $23,293.40 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 6 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,423 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 5 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,763 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,305 | $68.51 | $89,405.55 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 4 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,743 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,048 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 660 | $68.51 | $45,216.60 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,420 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,080 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057395 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238 Underlying: Common Stock · 238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 238 shares vested on December 1, 2023; the remaining 238 shares will vest on December 1, 2024. F4 · derivative.expiration_date: 238 shares vested on December 1, 2023; the remaining 238 shares will vest on December 1, 2024. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 119 | $69.22 | $8,237.18 |
DisclosureSEC source: 0001209191-23-057395 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,470 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057395 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,589 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054981 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,970 Underlying: Common Stock · 3,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,970 shares vested on November 8, 2023; the remaining 3,970 shares will vest on November 8, 2024. F4 · derivative.expiration_date: 3,970 shares vested on November 8, 2023; the remaining 3,970 shares will vest on November 8, 2024. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,449 | $60.29 | $87,360.21 |
DisclosureSEC source: 0001209191-23-054981 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,351 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054981 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052949 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 780 Underlying: Common Stock · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. F4 · derivative.expiration_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 135 | $68.02 | $9,182.70 |
DisclosureSEC source: 0001209191-23-052949 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,830 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052949 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,965 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032859 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 840 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 420 shares vested on May 25, 2023; the remaining 840 shares will vest in equal installments on May 25, 2024 and May 25, 2025. F4 · derivative.expiration_date: 420 shares vested on May 25, 2023; the remaining 840 shares will vest in equal installments on May 25, 2024 and May 25, 2025. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 146 | $84.72 | $12,369.12 |
DisclosureSEC source: 0001209191-23-032859 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,575 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032859 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,721 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 19:13 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 7,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021712 · doc4.xml · derivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,388 Underlying: Common Stock · 7,388 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: 2,462 shares will vest on the first anniversary date of the grant date, March 28, 2024; 2,463 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 2,463 shares will vest on the third anniversary date of the grant date, March 28, 2026. F3 · derivative.expiration_date: 2,462 shares will vest on the first anniversary date of the grant date, March 28, 2024; 2,463 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 2,463 shares will vest on the third anniversary date of the grant date, March 28, 2026. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 19:13 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Option · Derivative | 7,386 | $0.00 Strike: $87.46 | $0.00 |
DisclosureSEC source: 0001209191-23-021712 · doc4.xml · derivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,386 Underlying: Common Stock · 7,386 shares Expires 2033-03-28 F1 · derivative.exercise_date: 2,462 shares will vest on the first anniversary date of the grant date, March 28, 2024; 2,462 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 2,462 shares will vest on the third anniversary date of the grant date, March 28, 2026. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · derivative · entry 6 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947 Underlying: Common Stock · 473 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 473 shares vested on February 1, 2023; 473 shares will vest on February 1, 2024; and 474 shares will vest on February 1, 2025. F5 · derivative.expiration_date: 473 shares vested on February 1, 2023; 473 shares will vest on February 1, 2024; and 474 shares will vest on February 1, 2025. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 162 | $88.51 | $14,338.62 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 4 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,301 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,463 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · derivative · entry 5 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,830 Underlying: Common Stock · 1,609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,609 shares vested on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 1,609 shares vested on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 643 | $85.61 | $55,047.23 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,990 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.